Your browser is no longer supported. Please, upgrade your browser.
AMGN Amgen Inc. weekly Stock Chart
Amgen Inc.
IndexS&P 500 P/E14.23 EPS (ttm)12.53 Insider Own0.20% Shs Outstand613.87M Perf Week1.98%
Market Cap109.51B Forward P/E12.13 EPS next Y14.71 Insider Trans-0.97% Shs Float608.66M Perf Month-2.40%
Income8.08B PEG7.57 EPS next Q3.58 Inst Own80.20% Short Float1.43% Perf Quarter0.52%
Sales23.75B P/S4.61 EPS this Y14.80% Inst Trans-0.04% Short Ratio3.07 Perf Half Y-11.65%
Book/sh17.41 P/B10.25 EPS next Y5.29% ROA12.20% Target Price205.35 Perf Year-7.47%
Cash/sh42.84 P/C4.16 EPS next 5Y1.88% ROE61.40% 52W Range166.30 - 210.19 Perf YTD-8.36%
Dividend5.80 P/FCF17.50 EPS past 5Y13.70% ROI19.80% 52W High-15.13% Beta1.18
Dividend %3.25% Quick Ratio2.50 Sales past 5Y4.90% Gross Margin82.30% 52W Low7.27% ATR3.13
Employees21500 Current Ratio2.80 Sales Q/Q0.10% Oper. Margin42.10% RSI (14)47.94 Volatility1.60% 1.65%
OptionableYes Debt/Eq3.05 EPS Q/Q-2.10% Profit Margin34.00% Rel Volume1.05 Prev Close179.54
ShortableYes LT Debt/Eq2.71 EarningsJul 30 AMC Payout42.90% Avg Volume2.83M Price178.39
Recom2.30 SMA20-2.22% SMA501.01% SMA200-5.05% Volume2,987,154 Change-0.64%
May-23-19Upgrade Citigroup Neutral → Buy
May-21-19Initiated Credit Suisse Outperform $208
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jul-18-19 11:00PM  Amgen And Allergan's MVASI (bevacizumab-awwb) And KANJINTI (trastuzumab-anns) Now Available In The United States PR Newswire
04:13PM  These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger Investor's Business Daily
Jul-17-19 10:06AM  Biotech Stock Roundup: Galapagos & Hookipa Surge, AMGN Shelves Alzheimer's Study Zacks
Jul-16-19 02:14PM  Eisai boosts focus on Alzheimer's with new research facility, funding American City Business Journals
07:01AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jul-14-19 11:10AM  Health companies start reporting earnings next week: Here are 3 things to keep in mind MarketWatch
Jul-12-19 05:05PM  What Happened in the Stock Market Today Motley Fool
10:28AM  The Zacks Analyst Blog Highlights: DaVita, Fresenius, Baxter, Amgen and CVS Zacks
10:24AM  Amgen & Novartis' Alzheimer Studies End in Another Failure Zacks
10:19AM  Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug Benzinga
10:10AM  Why Amgen (AMGN) Could Beat Earnings Estimates Again Zacks
07:58AM  Dow Jones Futures: Illumina, Profitable Marijuana Stock Tumble; Amgen-Novartis Alzheimer's Drug Fails Investor's Business Daily
07:24AM  The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study Benzinga
06:47AM  Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar? Zacks
Jul-11-19 04:51PM  Amgen and Novartis drop Alzheimer's-prevention study after patients worsened MarketWatch
04:30PM  Amgen, Novartis And Banner Alzheimer's Institute Discontinue Clinical Research Program With BACE Inhibitor CNP520 For Alzheimer's Prevention PR Newswire
09:20AM  Trump's Order on Kidney Care Lifts These Dialysis Stocks Zacks
06:45AM  Amgen Falls 3%
05:14AM  Amgen, Novartis abandon two Alzheimers drug studies Financial Times
Jul-10-19 05:53PM  Mirati Inks Deal with Novartis to Evaluate Tumor Candidate Zacks
01:16PM  The 10 Biggest Healthcare Stocks Motley Fool
11:24AM  Court Ruling Topples Trump Order, No Price Display in TV Ads Zacks
10:14AM  Merck's Keytruda sBLAs for 6-Week Dosing to be Reviewed by FDA Zacks
08:14AM  Will Patent Woes Boost Pharma Stock Megamergers Further? Zacks
Jul-09-19 05:52PM  Roche Reveals New Hemlibra Data, Extends Spark Merger Deadline Zacks
05:32PM  Political Football Stocks
11:15AM  Merck, Amgen, and Eli Lilly Get a Drug Pricing Win in Court
08:00AM  Looking For Growth? Take A Look At These Biotechnology Stocks Investor's Business Daily
07:11AM  The Daily Biotech Pulse: Roche Presents Positive Hemlibra Data, Amgen's Tender Offer For Nuevolution Complete, Genmab Offering Benzinga
Jul-08-19 06:36PM  UPDATE 4-U.S. judge strikes down Trump administration rule requiring drug prices in TV ads Reuters
04:00PM  Amgen Announces The Outcome Of The Recommended Public Cash Offer To The Shareholders Of Nuevolution, Declares The Offer Unconditional And Completes The Offer PR Newswire
Jul-06-19 10:00AM  Here's Why Amgen Stock Gained 10% in June Motley Fool
Jul-05-19 08:09PM  The Top 10 Biotechnology Companies (JNJ, ROG.VX) Investopedia
Jul-04-19 10:31AM  Top Analyst Reports: Mastercard, Coca-Cola, Amgen & More Zacks
08:25AM  Should Amgen Inc. (NASDAQ:AMGN) Be Part Of Your Dividend Portfolio? Simply Wall St.
Jul-03-19 10:41AM  Biotech Braces for Busy Summer as 2019 M&A Volume Heats Up Bloomberg
10:22AM  Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance Zacks
Jul-01-19 11:12PM  How to Invest in Biotech Stocks Motley Fool
06:12PM  Roche's Tecentriq Gets CHMP Recommendation for Breast Cancer Zacks
09:43AM  Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval Zacks
Jun-30-19 08:00AM  3 Top Biotech Stocks to Buy Right Now Motley Fool
Jun-29-19 07:44AM  Here are the stock markets winners and losers in the first half of 2019 MarketWatch
06:00AM  3 Cancer-Treatment Stocks to Buy Motley Fool
Jun-28-19 05:45PM  Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
09:56AM  Amgen's Osteoporosis Drug Evenity Gets Adverse CHMP View Zacks
07:32AM  The Daily Biotech Pulse: Chiasma To Join R3K Index, EU Rejects Amgen's Osteoporosis Drug Application, Karuna IPO Benzinga
01:00AM  Amgen and UCB Provide Regulatory Update on Status of EVENITY (romosozumab) in the EU PR Newswire
Jun-27-19 02:10PM  Amgen's Rally Could Just Be Getting Started
Jun-25-19 04:00PM  Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket PR Newswire
11:39AM  Allergan acquisition is a major bailout for shareholders, according to analysts MarketWatch
11:02AM  The 10 Biggest Biotech Stocks Motley Fool
Jun-24-19 10:27AM  Allergan's Botox Wins FDA Nod for Upper Limb Spasticity in Kids Zacks
Jun-22-19 09:33AM  This would be the worst-case scenario for health stocks, according to UBS MarketWatch
Jun-21-19 09:15AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jun-20-19 05:50PM  Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
09:45AM  The Zacks Analyst Blog Highlights: Amgen, Alexion, Regeneron, Allergan and Savara Zacks
Jun-19-19 04:00PM  Amgen And The Institute For Protein Design (IPD) At University Of Washington Announce Unique Strategic Research Partnership PR Newswire
11:49AM  3 Large-Cap Biotech Stocks to Buy for Massive Gains InvestorPlace
11:04AM  The Zacks Analyst Blog Highlights: Broadcom, Amgen, NVIDIA, Bristol-Myers and Restaurant Brands Zacks
10:29AM  Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data Zacks
10:21AM  Merck's Keytruda Gets 2nd Label Expansion Approval in June Zacks
09:06AM  Big Drugmakers That May Tread the M&A Path After Pfizer Zacks
Jun-18-19 01:00PM  Top Analyst Reports for Broadcom, Amgen & NVIDIA Zacks
08:03AM  Roche's Rozlytrek Gets Approval in Japan for Solid Tumors Zacks
08:00AM  Looking For Great Stocks? First Use A Checklist To Identify Great Bases Investor's Business Daily
08:00AM  3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal Motley Fool
07:09AM  Shares of cancer-therapy companies skyrocket after Pfizer acquisition news MarketWatch
Jun-16-19 02:00AM  Amgen Announces BLINCYTO® (blinatumomab) Five-Year Overall Survival Data At EHA 2019 PR Newswire
Jun-14-19 05:48PM  UPDATE 1-U.S. drugmakers file lawsuit against requiring drug prices in TV ads Reuters
03:14PM  U.S. drugmakers file lawsuit against rule requiring drug prices in TV ads Reuters
08:47AM  The Daily Biotech Pulse: Hematology And Rheumatology Conference Presentations Take The Spotlight, Eton In-Licenses Epilepsy Drug NDA Benzinga
08:34AM  Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti Zacks
05:19AM  Drugmakers sue to stop rule requiring prices in TV ads Financial Times
Jun-13-19 07:13PM  FDA Approves Amgen And Allergan's KANJINTI (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab) PR Newswire
05:40PM  Roche Reports Positive Data on Rituxan for Pemphigus Vulgaris Zacks
04:12PM  Amgen, Biogen, Gilead and Novo Nordisk have very high capacity for M&A, says Moodys MarketWatch
09:36AM  Ligand Inks Oncology Drug Discovery Deal With PhoreMost Zacks
09:31AM  Keytruda & 4 Other Reasons to Invest in Merck's (MRK) Stock Zacks
Jun-12-19 06:33PM  Roche's Rituxan Gets Priority Review for Blood Disorder Zacks
05:50PM  Amgen (AMGN) Gains As Market Dips: What You Should Know Zacks
09:00AM  Amgen Publishes Offer Document With Respect To The Recommended Public Cash Offer To The Shareholders Of Nuevolution PR Newswire
08:33AM  Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer Zacks
Jun-11-19 09:54AM  Roche's Polivy Gets FDA Nod, Gazyva Meets Goals in Phase II Zacks
Jun-10-19 09:39AM  Roche Receives FTC Request for Further Data on Spark Buyout Zacks
Jun-07-19 04:00PM  Amgen To Present At The Goldman Sachs 40th Annual Global Healthcare Conference PR Newswire
09:59AM  Mirati Therapeutics Stock Will Fall From Here, Analyst Says
Jun-06-19 05:59PM  Is Amgen, Inc. (AMGN) A Good Stock To Buy? Insider Monkey
05:50PM  Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know Zacks
03:13PM  5 Healthcare Stocks to Pick Up From the Wreckage InvestorPlace
02:30PM  Should We Be Delighted With Amgen Inc.'s (NASDAQ:AMGN) ROE Of 75%? Simply Wall St.
09:22AM  Lilly's Emgality Gets FDA Approval for Cluster Headache Zacks
09:09AM  Was ASCO Quieter for Big Drug/Biotech Stocks This Year? Zacks
Jun-05-19 01:07PM  Amgen Cancer Treatment Candidate Had 'Adverse Events' in Almost Half of Patients
09:05AM  Pfizer to Launch Several Drugs Despite Generic Headwinds Zacks
08:00AM  Iovance and Amgen Are Making Cancer History Bloomberg
07:32AM  Amgen's early-stage study of cancer treatment had 'adverse events' in nearly half of its patients MarketWatch
07:00AM  Amgen Highlights the Versatility of the BiTE® Immuno-Oncology Platform in Multiple Tumour Types at ASCO 2019 CNW Group
07:00AM  Amgen Announces First Clinical Data Evaluating Investigational KRAS(G12C) inhibitor AMG 510 at ASCO 2019 CNW Group
Jun-04-19 06:45PM  Amgen Drug Breaks New Ground
05:06PM  FDA approves Lilly's migraine drug as first ever cluster headache treatment Reuters
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, and neuroscience. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Aranesp to treat anemia; Xgeva for skeletal-related events prevention; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; and EPOGEN to treat a lower-than-normal number of red blood cells. It also markets other products in various markets, including Kyprolis, Nplate, Vectibix, Repatha, NEUPOGEN, Parsabiv, Blincyto, Aimovig, Imlygic, Corlanor, Kanjintitm, and Amgevitatm. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaborative agreements with Novartis; UCB; Bayer HealthCare Pharmaceuticals Inc.; Syapse; and DaVita Inc., as well as strategic research partnership with the University of Washington's Institute for Protein Design. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorJul 03Option Exercise54.712,000109,42016,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJul 03Sale187.582,000375,16014,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJun 05Option Exercise54.712,000109,42016,219Jun 05 06:55 PM
SUGAR RONALD DDirectorJun 05Sale175.682,000351,36014,219Jun 05 06:55 PM
SUGAR RONALD DDirectorMay 01Option Exercise54.712,000109,42015,092May 03 05:37 PM
SUGAR RONALD DDirectorMay 01Sale175.732,000351,46013,092May 03 05:37 PM
SUGAR RONALD DDirectorApr 03Option Exercise54.712,000109,42015,092Apr 03 06:27 PM
SUGAR RONALD DDirectorApr 03Sale193.182,000386,36013,092Apr 03 06:27 PM
SUGAR RONALD DDirectorMar 06Option Exercise54.712,000109,42014,988Mar 08 07:47 PM
SUGAR RONALD DDirectorMar 06Sale188.882,000377,76012,988Mar 08 07:47 PM
SUGAR RONALD DDirectorFeb 07Option Exercise54.712,000109,42014,988Feb 11 09:27 PM
SUGAR RONALD DDirectorFeb 07Sale190.002,000380,00012,988Feb 11 09:27 PM
Jacks TylerDirectorDec 06Option Exercise82.6020,0001,652,00028,979Dec 10 08:46 PM
Jacks TylerDirectorDec 06Sale195.4120,0003,908,2328,979Dec 10 08:46 PM
Piacquad DavidSVP, Business DevelopmentNov 30Option Exercise54.696,500355,48545,128Dec 03 08:13 PM
Patton Cynthia MSVP & CCONov 29Option Exercise54.691,77797,18423,090Dec 03 08:11 PM
Patton Cynthia MSVP & CCONov 29Sale202.881,777360,52021,313Dec 03 08:11 PM
HENDERSON REBECCA MDirectorAug 10Option Exercise63.113,000189,33016,197Aug 14 08:29 PM